Robert Z. Orlowski, MD, PhD, from The University of Texas MD Anderson Cancer Center discusses combinations well tolerated in multiple Myeloma and that benefits are better when compared to lenalidomide alone at the 2017 American Society of Hematology.
Combinations Well Tolerated in Multiple Myeloma Benefits are better when compared to lenalidomide alone
